Clinical sleep care solution aims to reduce the impact of untreated sleep disorders on chronic diseases and people’s lives
LAS VEGAS, November 13, 2022 /PRNewswire/ — Primasun, a clinically backed end-to-end solution for treating complex sleep disorders, was launched today HTTH 2022. Formed as a joint venture between ResMed, a global leader in digital health and sleep technology, and Verily, a precision healthcare company owned by Alphabet, Primasun’s offering combines cutting-edge healthcare technology and advanced healthcare research into a comprehensive digital healthcare platform.
Despite being declared a public health epidemic by the CDC in 2014, insufficient sleep continues to have disastrous effects on people’s health, the workplace and the healthcare system – much of which can be attributed to poor access to medical care. While it is estimated that up to 70 million Americans struggling with an undiagnosed sleep disorder, there is only 1 sleep specialist per 43,000 Americans to help them find and receive care.
Through its preventative care model, Primasun works with employers and healthcare providers to identify at-risk groups and connects patients with board-certified sleep medicine professionals who take them from diagnosis to treatment in weeks.
“Sleep is the foundation of physical and mental health, and at Primasun we believe there is an opportunity to create a more efficient, equitable healthcare solution that will help patients clinically improve their sleep and in turn,…
